February 28, 2017 12:34 AM ET

Biotechnology

Company Overview of Ascenta Therapeutics, Inc.

Key Executives for Ascenta Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Marc Estes Lippman M.D.22 RelationshipsCo-Founder and Director71
Jeffrey Brill No RelationshipsAssociate Director of Clinical Development--
Carl J. Wheeler Ph.D.No RelationshipsVice President of Intellectual Property--

Ascenta Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Marc Estes Lippman M.D. 22 RelationshipsAscenta Therapeutics, Inc.71
View All Board Members

Ascenta Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
354.2K
Bonus
254.7K
Total Short Term Compensation
449.7K
Total Value of Options
17.6M
Compensation as of Fiscal Year
Ascenta Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

CTI BioPharma Corp. Announces Executive Changes, with Effect from March 20, 2017
February 27, 2017 6:30 AM ET
Rigel Pharmaceuticals, Inc. Announces Board Changes
February 24, 2017 10:24 PM ET
Sangamo Therapeutics, Inc. Announces Termination of Dale Ando as Chief Medical Officer
February 24, 2017 10:10 PM ET
Ian Smith Notifies Ophthotech Corporation Request Not to Be Nominates for Re-Election to the Board of Directors
February 24, 2017 9:14 PM ET
Santhera Pharmaceuticals Opens of U.S. Office in Burlington, MA; Appoints Todd Bazemore to Lead U.S. Operations in Burlington, MA
February 24, 2017 1:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ascenta Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.